Clifford Chance
Compulsory licensing and new provisions affecting IP holders during the Coronavirus crisis in France and globally
20 April 2020
Pharmaceutical companies and screening test manufacturers are facing new major challenges due to the global health crisis relating to the coronavirus (COVID-19).
To strike the right balance between the interests of rights holders, third parties and the public, exceptions and limitations to patent rights have been promulgated in France and abroad.
Download PDF
